O	0	10	Comparison
O	11	13	of
O	14	22	fracture
O	22	23	,
O	24	38	cardiovascular
O	39	44	event
O	44	45	,
O	46	49	and
O	50	56	breast
O	57	63	cancer
O	64	69	rates
O	70	72	at
O	73	74	3
O	75	80	years
O	81	83	in
O	84	98	postmenopausal
O	99	104	women
O	105	109	with
O	110	122	osteoporosis
O	122	123	.

O	124	126	To
O	127	134	compare
O	135	140	event
O	141	146	rates
O	147	150	for
O	151	163	osteoporotic
O	164	173	fractures
O	173	174	,
O	175	189	cardiovascular
O	190	196	events
O	196	197	,
O	198	201	and
O	202	208	breast
O	209	215	cancer
O	216	218	in
O	219	233	postmenopausal
O	234	239	women
O	240	244	with
O	245	257	osteoporosis
O	257	258	.

O	259	260	A
O	261	272	prospective
O	272	273	,
O	274	287	observational
O	288	293	study
O	294	296	of
O	297	300	the
O	301	308	placebo
O	309	314	group
O	315	317	in
O	318	321	the
O	322	328	double
O	328	329	-
O	329	334	blind
O	334	335	,
O	336	346	randomized
O	347	355	Multiple
O	356	364	Outcomes
O	365	367	of
O	368	378	Raloxifene
O	379	389	Evaluation
O	390	395	trial
O	395	396	.

O	397	400	One
O	401	408	hundred
O	409	415	eighty
O	416	424	clinical
O	425	433	research
O	434	441	centers
O	442	444	in
O	445	447	25
O	448	457	countries
O	457	458	.

B-eligibility	459	473	Postmenopausal
I-eligibility	474	479	women
O	480	481	(
O	481	482	n
O	482	483	=
B-total-participants	483	484	2
I-total-participants	484	485	,
I-total-participants	485	488	565
O	488	489	,
O	490	494	mean
O	495	498	age
O	498	499	=
B-age	499	501	67
O	501	502	)
B-eligibility	503	507	with
I-eligibility	508	520	osteoporosis
O	521	525	were
O	526	531	given
B-intervention	532	539	calcium
O	540	541	(
O	541	544	500
O	545	547	mg
O	547	548	/
O	548	549	d
O	549	550	)
O	551	554	and
B-control	555	562	vitamin
I-control	563	564	D
O	565	566	(
O	566	569	400
O	569	570	-
O	570	573	600
O	574	576	IU
O	576	577	/
O	577	578	d
O	578	579	)
O	580	591	supplements
O	591	592	.

O	593	596	The
O	597	607	occurrence
O	608	610	of
O	611	613	at
O	614	619	least
O	620	623	one
B-outcome	624	627	new
I-outcome	628	636	fracture
I-outcome	636	637	,
I-outcome	638	652	cardiovascular
I-outcome	653	658	event
I-outcome	658	659	,
I-outcome	660	662	or
I-outcome	663	669	breast
I-outcome	670	676	cancer
I-outcome	677	686	diagnosis
O	687	689	at
O	690	691	3
O	692	697	years
O	698	701	was
O	702	712	identified
O	713	716	and
O	717	728	adjudicated
O	728	729	.

O	730	733	The
O	734	744	occurrence
O	745	747	of
O	748	751	any
O	752	760	fracture
O	761	764	was
O	765	768	the
O	769	773	most
O	774	780	common
O	781	786	event
O	787	789	in
O	790	795	these
O	796	801	women
O	801	802	.

O	803	805	In
O	806	811	women
O	812	819	without
O	820	829	prevalent
O	830	839	vertebral
O	840	849	fractures
O	850	851	(
O	851	852	n
O	852	853	=
B-total-participants	853	854	1
I-total-participants	854	855	,
I-total-participants	855	858	627
O	858	859	)
O	859	860	,
O	861	864	the
B-outcome	865	870	event
I-outcome	871	876	rates
O	877	880	per
O	881	882	1
O	882	883	,
O	883	886	000
O	887	894	patient
O	894	895	-
O	895	900	years
O	901	905	were
O	906	908	45
O	908	909	.
O	909	910	4
O	911	914	for
B-outcome	915	918	any
I-outcome	919	927	fracture
O	927	928	,
O	929	931	15
O	931	932	.
O	932	933	2
O	934	937	for
B-outcome	938	947	vertebral
I-outcome	948	956	fracture
O	956	957	,
O	958	959	4
O	959	960	.
O	960	961	7
O	962	965	for
B-outcome	966	974	clinical
I-outcome	975	984	vertebral
I-outcome	985	993	fracture
O	993	994	,
O	995	996	0
O	996	997	.
O	997	998	9
O	999	1002	for
B-outcome	1003	1006	hip
I-outcome	1007	1015	fracture
O	1015	1016	,
O	1017	1018	8
O	1018	1019	.
O	1019	1020	3
O	1021	1024	for
B-outcome	1025	1028	any
I-outcome	1029	1043	cardiovascular
I-outcome	1044	1049	event
O	1049	1050	,
O	1051	1054	and
O	1055	1056	5
O	1056	1057	.
O	1057	1058	2
O	1059	1062	for
B-outcome	1063	1066	all
I-outcome	1067	1073	breast
I-outcome	1074	1080	cancer
O	1080	1081	.

O	1082	1084	In
O	1085	1090	women
O	1091	1095	with
O	1096	1105	prevalent
O	1106	1115	vertebral
O	1116	1125	fractures
O	1126	1127	(
O	1127	1128	n
O	1128	1129	=
B-total-participants	1129	1132	938
O	1132	1133	)
O	1133	1134	,
O	1135	1138	the
B-outcome	1139	1144	event
I-outcome	1145	1150	rates
O	1151	1154	per
O	1155	1156	1
O	1156	1157	,
O	1157	1160	000
O	1161	1168	patient
O	1168	1169	-
O	1169	1174	years
O	1175	1179	were
O	1180	1183	117
O	1183	1184	.
O	1184	1185	4
O	1186	1189	for
O	1190	1193	any
B-outcome	1194	1197	new
I-outcome	1198	1206	fracture
O	1206	1207	,
O	1208	1210	77
O	1210	1211	.
O	1211	1212	1
O	1213	1216	for
B-outcome	1217	1220	new
I-outcome	1221	1230	vertebral
I-outcome	1231	1239	fracture
O	1239	1240	,
O	1241	1243	25
O	1243	1244	.
O	1244	1245	7
O	1246	1249	for
B-outcome	1250	1258	clinical
I-outcome	1259	1268	vertebral
I-outcome	1269	1277	fracture
O	1277	1278	,
O	1279	1280	5
O	1280	1281	.
O	1281	1282	8
O	1283	1286	for
B-outcome	1287	1290	hip
I-outcome	1291	1299	fracture
O	1299	1300	,
O	1301	1303	15
O	1303	1304	.
O	1304	1305	1
O	1306	1309	for
B-outcome	1310	1313	any
I-outcome	1314	1328	cardiovascular
I-outcome	1329	1334	event
O	1334	1335	,
O	1336	1339	and
O	1340	1341	2
O	1341	1342	.
O	1342	1343	6
O	1344	1347	for
B-outcome	1348	1351	all
I-outcome	1352	1358	breast
I-outcome	1359	1365	cancer
O	1365	1366	.

O	1367	1370	The
O	1371	1377	effect
O	1378	1380	of
O	1381	1390	prevalent
O	1391	1399	fracture
O	1400	1406	status
O	1407	1409	on
O	1410	1415	event
O	1416	1421	rates
O	1422	1425	was
O	1426	1429	not
O	1430	1439	dependent
O	1440	1442	on
O	1443	1450	whether
O	1451	1456	women
O	1457	1461	were
O	1462	1467	older
O	1468	1470	or
O	1471	1478	younger
O	1479	1483	than
O	1484	1486	65
O	1486	1487	,
O	1488	1491	but
O	1492	1497	women
O	1498	1502	aged
O	1503	1505	65
O	1506	1509	and
O	1510	1515	older
O	1516	1519	had
O	1520	1521	a
O	1522	1523	3
O	1523	1524	.
O	1524	1525	6
O	1526	1531	times
O	1532	1539	greater
O	1540	1550	occurrence
O	1551	1553	of
O	1554	1568	cardiovascular
O	1569	1575	events
O	1576	1580	than
O	1581	1588	younger
O	1589	1594	women
O	1594	1595	,
O	1596	1608	irrespective
O	1609	1611	of
O	1612	1621	prevalent
O	1622	1630	fracture
O	1631	1637	status
O	1637	1638	.

O	1639	1644	These
O	1645	1649	data
O	1650	1652	on
O	1653	1656	the
O	1657	1665	relative
O	1666	1675	incidence
O	1676	1678	of
O	1679	1689	clinically
O	1690	1701	significant
O	1702	1710	skeletal
O	1711	1714	and
O	1715	1720	extra
O	1720	1721	-
O	1721	1729	skeletal
O	1730	1738	outcomes
O	1739	1742	may
O	1743	1745	be
O	1746	1752	useful
O	1753	1755	in
O	1756	1764	choosing
O	1765	1767	an
O	1768	1773	agent
O	1774	1777	for
O	1778	1784	health
O	1785	1796	maintenance
O	1797	1800	for
O	1801	1815	postmenopausal
O	1816	1821	women
O	1822	1826	with
O	1827	1839	osteoporosis
O	1839	1840	.
